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INTRODUCTION
Early  recognition  of  critical  illness  followed  by  time  sensitive  goal  directed 
management is  crucial to improve the survival. Among  the critically ill children, shock 
occurs in most of the children. The mortality rate among the  patients with shock varies 
from 20% to 50%. Shock is one of the most  dramatic, dynamic and life threatening 
problems faced by the physician in  critical care settings.(1)
CLASSIFICATION OF SHOCK :
There are five major types of shock namely :-
Hypovolemic shock
Septic shock
Cardiogenic shock
Distributive shock
Obstructive shock
Hypovolemic shock:-
Hypovolemic shock is charecterized by  decreased preload secondary to internal 
or external losses.
Eg.
Loss of components of intravascular volume:-
Blood: hemorrhage,
Plasma:burns, nephrotic syndrome
Water and electrolytes: diarrhea, vomiting, diabetes
Cardiogenic shock:-
Cardiogenic shock is  charecterised by  cardiac pump failure  secondary to poor 
myocardial function.
Eg.
Congenital heart disease
Cardiomyopathies:infectious or acquired, dilated or restrictive
Ischemia
Dysrhythmias
Septic shock:-
Septic shock includes multiple forms of  shock.  That  includes hypovolemic by 
third  spacing;  distributive  by  early   shock  with  decreased  afterload;  cardiogenic  by 
depression of myocardial function by endotoxins.
Caused by bacterial, viral or fungal infection.
Distributive shock:-
Distributive shock is due to the abnormalities of vasomotor tone, loss of  venous 
capacitance decreases preload, loss of arterial capacitance decreases afterload or 
systemic blood pressure.
Eg. 
Anaphylaxis,
Neurologic: loss of sympathetic vascular tone secondary to spinal cord or 
brainstem injury.
Drugs.
Obstructive shock:-
Obstructive shock is due to  significant obstruction to right or left 
heart function, or restriction of all cardiac chambers.
Eg.
Pericardial tamponade,
Tension pneumothorax.
STAGES OF SHOCK(2,3)
Early or Compensated Shock
In early compensated shock several compensatory mechanism are activated. It is 
defined by the presence of systolic blood pressure within the normal range with signs of 
symptoms of inadequate tissue and organ perfusion. Vital organ function is maintained.
In  children,  vascular  tone  is  maintained  in  low flow  states  (4)  of  septic  and 
cardiogenic shock. Therefore, children can often maintain their blood pressure until they 
are in profound shock.
If  shock  is  left  untreated,  the  compensatory  mechanisms  will  fail  and 
uncompensated  shock  develops.  Failure  of  normalization  of  peripheral  pulses,  skin 
temp, and capillary refill with treatment predicts death from shock. (5)
Children are mostly dependent on their heart rate to increase cardiac output.
Ability  to  increase  contractility  in  response  to  catecholamine  stimulation  is 
limited  due  to  insufficient  muscle  mass  and  "stiffness"  of  the  young  myocardium 
compared to  the adult  heart.  (6)  When the compensatory  mechanisms are  activated, 
children become dependent on intravascular volume (preload) to maintain CO. (7) Since 
afterload is already increased in an effort to maintain SVR and BP, maintaining adequate 
intravascular volume is the key aspect of successful resuscitation
Uncompensated shock
When signs of shock are associated with systolic hypotension then it is called as 
decompensated shock. Hypotension is a late sign of shock.
When  the  compensatory  mechanisms  fail  to  meet  the  increased  metabolic 
demands at the tissue level uncompensated shock with hypotension will develop. Tissue 
hypoxemia and ischemia will trigger anaerobic metabolism resulting in lactate build-up 
and the development of metabolic acidosis. A number of other vasoactive metabolites 
such as adenosine, nitric oxide are also released and accumulate locally.
Once the blood pressure falls, the patient will progress into irreversible shock if 
the perfusion pressure to tissues is not restored. Irreversible shock, as the name implies, 
is the point of no return and the mortality rate is high irrespective of interventions.
CARDIOPULMONARY ASSESSMENT                                                
Respiratory rate:-
Tachypnea is one of the signs of shock. Bradypnea or normal respiratory rate in 
the presence of shock (relative bradypnea) occurs in profound shock.
Skin colour:- 
Normal or abnormal (cyanosis / dusky / pallor / mottling / hyperpink)
Heart rate :- 
Tachycardia is the earliest sign of shock. Bradycardia or normal heart rate in the 
presence of shock (relative bradycardia) may occur in late decompensated shock.
Pulse volume:-
Pulse volume is assessed by simultaneously palpating the central (femoral)  and 
distal (dorsalis pedis) pulses. In shock there may be thready  distal pulse  or absent distal 
pulse.in warm shock of sepsis,there will be bounding distal  pulses.
Capillary refill time :-
When capillary refill is evaluated, lift  the extremity slightly above the heart  level 
to ensure assessment of arteriolar capillary and not venous stasis. It is  prolonged in 
shock and cold ambient temperature.
Liver span :-
It provides noninvasive information of myocardial contractility. Increase in  liver 
span suggests cardiogenic component.
Blood pressure :-
Shock may be present with normal, low or high blood pressure.
Normal blood pressure: compensated shock
Hypotension : decompensated shock
Hypotension is not synonymous with shock
Table – 1: Age specific vital signs(8) 
AGE RESPIRATORY RATE per min
HEARTRATE 
per min
SYSTOLIC  BP 
mm of hg
newborn 30-60 90-180 50-70
6 months 24-40 85-170 65-106
1 year 20-40 80-140 72-110
3 years 20-30 75-120 78-114
6 years 18-25 70-110 80-116
8 years 18-25 65-110 84-122
10 years 16-20 65-110 90-130
12 years 14-20 60-110 94-136
The above table shows the normal age specific vital signs.
RATE AND VOLUME OF FLUID ADMINISTRATION:-
Start  fluid  resuscitation  for  shock  with  20  ml  /kg  of  isotonic  crystalloid 
administered as a bolus over 5 to 20 minutes.  Then repeat  boluses of 20  ml/kg as 
needed to restore blood pressure and perfusion(9).
Give fluid boluses more rapidly to correct hypotensive shock and septic shock. 
Resuscitation of most  children in hypotensive or septic shock may  require atleast 40 to 
80 ml/kg of isotonic crystalloid solution during the first hour(s) of therapy. As much as 
240 ml /kg has been used in the first 8 hours of  septic shock therapy.(10,11)
Table - 2
TYPE OF SHOCK VOLUME OF FLUID RATE OF DELIVERY
hypovolemic, 
distributive and 
obstructive shock
20 ml/kg bolus (repeat 
PRN)
deliver rapidly over 5 
to 10 minutes
cardiogenic shock
5 to 10 ml/kg bolus 
(repeat PRN)
deliver more slowly 
over 10 to20 minutes
The above table provides a general guide to fluid boluses and rates of  delivery 
based on the underlying cause of shock.
INOTROPES(12,13)
1. DOPAMINE
Classificati
on:catecholamine,vasopressor,inorope
Dopamine is a chemical precursor of epinephrine, possessing alpha and beta 
receptor – simulating actions.  The specific effects of dopamine are related to the dose 
delivered.
LOW DOSE ---- < 2mcq/kg/minute (Dopaminergic effect)
Vasodilation of renal and splanchnic (pertaining to the viscera) arteries.  Doses at 
this level promote blood flow and increased GFR (glomerular filtration rates in patients 
who become resistant to diuretics).  Urine output may increase without significant effect 
on blood pressure or heart rate.
INTERMEDIATE DOSE ---- 2 to 10 mcq/kg/minute
At this delivery rate, beta-adrenergic receptor activity is increased in the heart. 
Partial  antagonism  of  alpha  –  adrenergic  receptors  will  mediate  vasoconstriction. 
Cardiac  output  and  CVP (central  venous  pressure)  will  increase  with  only  modest 
increase in (SVR) systemic vascular resistance.
HIGH DOSE --- 10 to 20 mcq/kg/minute
Alpha effects dominate at this delivery rate.   This results in renal,  mesenteric, 
peripheral arterial and venous vasoconstriction.  This will increase SVR, PVR, pre-load, 
heart  rate  and  potentiate  arrhythmias.   Monitor  the  patient  carefully  for  decreased 
circulation in the extremities.
If extravasation occur, the infusion should be immediately stopped. 
ADVERSE EFFECTS:
Dopamine extravasation can cause severe tissue necrosis
• Tachycardia 
• Supraventricular tachycardia 
• Ventricular arrhythmias 
• Pulmonary congestion 
• Nausea 
• Vomiting 
• Hypotension when used concomitantly with phenytoin
DOBUTAMINE
Dobutamine  is  chemically  related  to  dopamine.   It  has  Beta  1  and  Alpha 
adrenergic  stimulating  qualities  but  does  not  affect  renal  blood flow like  dopamine. 
Dobutamine  will  increase  renal  and  mesenteric  blood  flow,  but  it  achieves  this  by 
increasing cardiac output
The maximum effective dose of dobutamine depends on the individual patient. 
It’s inotropic effect is considered superior to dopamine.
INITIAL DOSE 2 TO 3 mcg/kg/minute
Titrate for desired effect including:
Increased cardiac output
          Decreased PAWP (PCW, wedge)
Decreased PVR
Increased coronary blood flow
 USUAL DOSE 2.5 to 10 mcq/kg/minute
Desired effects include:
Increased cardiac output
Increased stroke volume
This dose will not increase heart rate or cause vasoconstriction.
ADVERSE EFFECTS:
• Tachycardia 
• Arrhythmias 
• Blood pressure fluctuation 
• Myocardial ischemia 
• Headache 
• Nausea 
• Tremors 
• Hypokalemia 
EPINEPHRINE
Epinephrine has both “Alpha” and “Beta” adrenergic agonist activity depending 
on the dose administered.  As a continual infusion,epinephrine will increase heart rate, 
cardiac conduction, contractility and vasodilation, thus increasing cardiac output.
As  the  dose  gets  higher,  alpha  receptors  are  stimulated  resulting  in  increased 
vascular resistance and blood pressure.
Epinephrine accelerates the sinus rate of the heart and may precipitate ventricular 
dysrhythmias in the presence an ischemic heart.
Epinephrine delivered as a continuous infusion is always diluted per institutional 
policy and always used with an infusion pump.  Intensive monitoring of the patient is 
required.
CARDIAC  RHYTHMS  REQUIRING  EPINEPHRINE  USE  DURING  CARDIAC 
ARREST.
1. Ventricular Fibrillation 
2. Pulseless Ventricular Tachycardia – Unresponsive to initial countershock. 
3. Asystole 
4. Pulseless Electrical Activity 
5. Dosage --- 1mg IV bolus 
6. Intervals --- Should not exceed 3 – 5 minutes 
ADVERSE EFFECTS:
Cardiac Arrhythmias Dizziness
Palpitations           Weakness
Tachycardia           Temors
Sweating           Headache
Nausea and vomiting Apprehension
Respiratory difficulty Nervousness
Pallor           Anxiety
NOREPINEPHRINE
Norepinephrine is a potent alpha – receptor antagonist with minimal effect on beta 
2  receptors.   Norephinephrine  increases  myocardial  contractility  due  to  its  beta  1 
adrenergic effects.  Its potent alpha effect leads to arterial and venous constriction.  Use 
of norephinephrine is effective in septic shock and neurogenic shock.
Hypotensive shock
IV/IO    0.1 to 0.2microgram/kg. per minute   extravasation produces ischemic 
necrosis and sloughing of superficial tissues
Use  of  a  central  line  is  recommended  due  to  the  risk  of  extravasation  into 
surrounding tissue.
PRECAUTIONS
1. Possible  inaccurate  peripheral  blood  pressure  measurements  due  to 
vasoconstriction. 
2. Increased myocardial oxygen requirements. 
3. Arrhythmias 
REVIEW OF LITERATURE
Daljit singh et al(14),conducted a prospective study at Punjab,to determine the 
frequency,etiology,type and outcome of shock in hospitalized children in the age group 
of  1 month to 15 years. There were 98 cases of shock, constituting 4.3% out of total 
admissions. Mean age was 2.8 ± 3.4 years. Maximum number of patients (39) was seen 
in infancy. Hypovolemic shock due to acute diarrheal disease was the commonest type 
(45.9%) followed by septic, cardiogenic and distributive shock. Compensated stage was 
common in hypovolemic shock (88.9%) whereas majority of patients with septic shock 
(73.5%) presented in decompensated stage. Overall survival was 73.6%. The survival 
rate was best in hypovolemic shock (97.7%) followed by septic(53.3%) and cardiogenic 
shock(43.7%).  Inotropes  and  ventilatory  support  were  required  in  46%  and  23% 
patients, respectively. Diagnosis and management of shock in compensated stage carried 
better prognosis than in uncompensated shock irrespective of the age of the patient
Kutko et al(15), in a retrospective study observed that overall mortality rate in 80 
patients with septic shock was 13.5%. There were difference in mortality rates between 
patients  requiring  one  inotropic  agent  (0%)  and  patient  requiring  multiple  inotropic 
agents (42.9%) and between patients with multiple system failure (18.6%) and those 
without  multiorgan  system  failure  (0%).Finally  the  concluded  the  mortality  rate  in 
pediatric septic shock is lower than has been previously reported and also concluded that 
mortality from septic shock occurs most frequently in the context of multiple  organ 
system failure.
Jacobs  RF  et  al(16),  in   a  retrospective  analysis  of  2110  admissions  to  the 
pediatric  intensive  care  unit,identified  564  cases  of  septicshock(26.7%  of  the  total 
admissions).study was conducted in university of Arkansas for medical sciences,Little 
Rock.In this study population,inotropic support required in 268(47.5%) patients.Septic 
shock with  confirmed  bacterial  infection  occure  in  143 patients(25.2%).They  finally 
concluded  that  septic  shock  occurs  more  frequently  in  children  than  previously 
appreciated. 
Patel  et al(17),in a prospective study observed that the 28 day mortality rate was 
50%(67/134) with dopamine has the initial vasopressor compared to 43%(51/118) for 
nor-epinephrine treatment(p=0.282).There was significantly  greater incidence of sinus 
tachycardia with dopamine(27.5%) than nor-epinephrine(5.3%) and arrhythmias noted 
with  dopamine  treatment  23.3%  compared  to  nor-epinephrine  treatment(5.3%).p 
(<0.0001) respectively.In this protocol directed vasopressor support strategy for septic 
shock ,dopamine and nor-epinephrine were equally effective as initial agents as judged 
by 28 day mortality rates.However there were significantly more cardiac arrhythmias 
with dopamine treatment.
Santhanam I et al(18), in a study conducted in Pediatric Emergency Medicine, 
Institute of Child Health and Hospital for Children Madras Medical College, Chennai, 
India. Concluded that Early recognition of shock is the key to successful resuscitation in 
critically ill children. Often, shock results in or co-exists with myo-cardial dysfunction 
or acute lung injury. Recognition and appropriate management of these insults is crucial 
for  successful  outcomes.  Resuscitation  should  be  directed  to  restoration  of  tissue 
perfusion and normalization of cardiac and respiratory function. The underlying cause of 
shock  should  also  be  addressed  urgently.  The  physiological  response  of  individual 
children to shock resuscitation varies and is often variable and unpredictable. Therefore, 
repeated assessments with continuous, non-invasive monitoring are needed for taking 
appropriate decisions in the ED. Although global indices of tissue oxygen delivery such 
as  the  mixed  venous  oxygen  saturation  (SvO(2))  help  in  targeting  therapies  more 
accurately,  it  is  often  unavailable  in  emergency  settings.  Isotonic  fluids  form  the 
cornerstone of treatment and the amount required for resuscitation is based on etiologies 
and therapeutic  response.  After  resuscitation  has  been initiated,  targeted  history  and 
clinical evaluation must be performed to ascertain the cause of shock. Management of 
co-morbidities  such  as  asthma  and  seizures  should  be  implemented  simultaneously. 
Inotropes, respiratory support, antibiotics and steroids may also be needed during the 
management  of  shock.  While  the  management  of  shock  can  be  protocol  based,  the 
treatment  needs  to  be  individualized  depending  on  the  suspected  etiology  and 
therapeutic response.
JUSTIFICATION OF THE STUDY
Around 800 children are treated in pediatric intensive care unit every year. Of this 
more than 500 cases are treated for shock with vasoactive agents.
There are not many publications in India in this subject, even though large number 
of children are on vasoactive agents. Hence , we want to stud  the various aspects of 
vasoactive agents.
Traditionally all over the world vaoactive agents are infused via central vein under 
strict invasive monitoring. For a resource poor country like India,v asoactive agents are 
infused in peripheral venous lines. Based on unproved data available at our institution , 
adverse effects of vasoactive agents in peripheral vein infusion is very few.
Being life saving medications, the vasoactive agents can be used in peripheral 
hospitals when much expenditure on monitoring is not feasible. If the safety profile of 
use of these agents in peripheral line can be documented, it may be helpful in using the 
drugs in prehospital stabilization during transfer of the patient in resource poor settings.
OBJECTIVE OF THE STUDY
Critically ill children admitted with different kinds of shock 
are  treated in  Pediatric  intensive care  unit  of  the tertiary care 
center  with  various  types  of  vasoactive  agents  like 
dopamine,dobutamine,epinephrine and norepinephrine.
Objective of this study is to find out:- Indications and adverse outcome among 
children treated with above mentioned vasoactive agents.
MATERIALS AND METHODS
Study design:-
           Descriptive study
Study place:-
        Pediatric intensive care unit , Institute of child health and hospital for children,  
Egmore, Chennai.
Study period:-
       One year,from October 21st , 2008 to October 20th ,2009.
Inclusion criteria:-
       All children beyond 30 days and upto 12 years, presenting with shock requiring 
vasoactive agents either  started in emergency room or PICU will  be included in the 
study.
Exclusion criteria:-
• Children less than 30 days of age.
• Children for whom vasoactive agents started prior to hospitalization   or in the 
ward and then referred to PICU.
MANOEUVER
 Patient in the age group of one month to 12 years admitted for shock in PICU 
,during the period   from October 21st ,  2008 to October 20th,  2009; who fulfill  the 
inclusion  criteria were included in the study.
Cardiopulmonary assessment were done and entry made in the data sheet. All sick 
children  were  initially  evaluated  in  the  emergency  room of  the  hospital  and  initial 
stabilization of the patient including airway, breathing followed by fluid resuscitation 
were carried out. Those patient who require inotropic support was started either in the 
emergency room or in the PICU according to the condition of the patient, according to 
the availability of the bed in the PICU, the children were admitted there. When there is 
no availability of bed in PICU, the child would be shifted to the concerned ward and 
those cases were excluded from the study.
Eligible  children are registered for  the study and the following particulars  are 
collected through proforma:-
• Type of shock / degree of shock.
• Cardiopulmonary status while starting vasoactive agents (heart rate, respiratory rate, 
blood pressure, capillary refilling time,liver span).
• Amount of fluid received before starting vasoactive agents. 
• Vasoactive agents used.
• IV line used- central / peripheral / intraosseous route.
• Starting dose, maximum dose, time taken to reach the maximum dose of vasoactive 
agent.
• When tapered? / Whether dose  increased after tapering?
• Duration of vasoactive agents used.
• Whether restarted?
• Complications like extravasations, arrhythmias, hypertension, and hyperglycemia.
• Number of IV lines used.
• Number of infusion pumps used.
• Monitoring  heart  rate,  respiratory  rate,  blood  pressure,  pulse  volume,  capillary 
refilling time, urine output, saturation-
o -2nd hourly in first 6 hours 
o -4th hourly in the next 24 hours
o -6th hourly after that; till 12 hours after stopping the vasoactive agents.
• Intubation needed or not / duration of ventilation / manual or mechanical.
• Lab abnormalities if any.
• Outcome / duration of stay in the PICU.
The patients  were managed according to the protocol  adopted from text  book of 
pediatric intensive care and as per PALS guidelines.
CASE DEFINITION
Hypovolemic shock:-
Children were classified as having hypovolemic shock based on the definitive 
history of fluid loss and signs of dehydration.
Cardiogenic shock:- 
Clinically diagnosed by features of shock and cardiac involvement as evidenced 
by the presence of gallop, muffling of heart sounds and signs of underlying heart disease 
if any and increasing liver span.
Septic shock:-
History  compatible  with  infection  and  children  having  features  of  systemic 
inflammatory response syndrome (hyper/hypothermic, tachycardia, tachypnoea).
Distributive shock:-
Patients with acute exacerbation of asthma, status epilepticus and other cause of 
distributive shock, without evidence of sepsis and causes of shock.
Decompensated shock:-
Features of shock with hypotension.
Compensated shock:-
It is defined by the presence of systolic blood pressure within normal range with 
signs of symptoms of inadequate tissue and organ perfusion.
Adverse outcome:-
Extravasation,  hyperglycemia,  arrythmias,  hypertension  are  taken  as  adverse 
outcome.
Inotrope(s) used:-
Either  single  inotrope  or  more  than  one  inotropes  used  was  recorded. 
Cardiopulmonary assessment before starting vasoactive agents and monitoring till  12 
hours after stopping the inotrope were recorded.
Ventilatory support:-
If ventilatory support was given then the type of ventilation given were recorded 
either manual or mechanical or both.
Outcome :-
It is classified as discharged, expired and discharged against medical advise.
STATISTICAL ANALYSIS
As the data collected were discrete, the statistical method applied were properties 
of usage of inotropes and the outcome. The outcome as against the total number of cases 
was evaluated.
Data was entered in the Microsoft office excel and analysed using SPSS ver 11.0 
for windows. As the variables are in qualitative form we have used chi square test in the 
univariate  analysis  to  observe  the  association  between  the  study  variables  and  the 
outcome.
OBSERVATIONS
Total number of cases studied:-204
Total number of PICU admission during the one year study period is:-812
So, 21.1% of the PICU admission is taken into the study group as they fit  for the 
inclusion criteria mentioned earlier.
Table -3: AGE DISTRIBUTION OF CHILDREN 
TREATED WITH INOTROPES
Age in months No. of cases percentage
1-12 120 58.8%
13-60 56 27.5%
61-120 21 10.3%
>120 7 3.4%
total 204 100%
From the above table it is evident that most of the children affected with shock 
and treated with inotropes are children less than one year(58.8%).
Table – 4: SEX DISTRIBUTION OF CHILDREN 
TREATED WITH INOTROPES
Sex No. of cases percentage
Female 95 46.6%
Male 109 53.4%
total 204 100%
The above table shows that male children were more affected than the female 
children.
Table – 5: TYPES OF SHOCK
S.no. Type of shock No. of cases Percentage
1 Hypovolemic 17 8.3%
2 Cardiogenic 43 21.1%
3 Septic 135 66.2%
4 Distributive 8 3.9%
5 Septic cardiogenic 1 0.5%
Total 204 100%
From the above table, it is evident that septic shock (66.2%)  is the commonest 
type  of  shock  among  the  study  group,  with  cardiogenic  (21.1%)  and  hypovolemic 
(8.3%) being the next two categories. 
Table - 6 :DEGREE OF SHOCK
S.No Degree of shock No of cases Percentage
1. Compensated 181 88.7 %
2. Decompensated 23 11.3 %
Total 204 100.0 %
From the above table, it is clear that the compensated shock (88.7%)  is much 
more higher than the decompensated shock (11.3%) in our study group.
Table – 7 : AMOUNT OF FLUID GIVEN BEFORE 
STARTING INOTROPES
S.No
Amount of fluid 
ml/kg
No. of cases Percentage
Cumulative 
percentage
1. <20 104 51.0 % 51.0 %
2. 20 – 40 49 24.0 % 75.0 %
3. 40 – 60 46 22.5 % 97.5 %
4. 60 – 80 5 2.5 % 100.0 %
        204   100.0 %
It is evident from the above table that 97.5% of the children in the study received 
less than 60 ml/kg of fluid,of which 104 children (51%) received less than 20 ml/kg of 
fluid before starting inotropes.
Table – 8 : TOTAL FLUIDS GIVEN IN 24 HOURS
S.No
Amount of fluid 
given in 24 hrs
ml/kg
No of cases Percentage
1. <60 66 32.4 %
2. 60 – 100 66 32.4 %
3. 100 – 150 41 20.1 %
4. 150 – 200 12 5.9 %
5. 200 – 250 12 5.9 %
6. 250 – 300 6 2.9 %
7. >300 1 0.5 %
204 100.0 %
About 64.7%(132 cases) of the children received less than 100 ml/kg of fluid  in 
the first 24 hours. Remaining 35.3% (72 cases) needed more than 100 ml/kg in the first 
24 hours
Table – 9: VASOACTIVE AGENTS USED
S.No Vasoactive agents No of cases Percentage
1. Dopamine (1) 82 40.2 %
2. Dobutamine (2) 14 6.9 %
3. Noradrenaline (3) - -
4. Adrenaline (4) 10 4.9 %
5. 1 + 3 45 22.1 %
6. 1 + 4 23 11.3 %
7. 2 + 4 5 2.5 %
8. 1 + 3 + 4 9 4.4 %
9. 1 + 2 7 3.4 %
10. 2 + 3 2 1.0 %
11. 1 + 2 + 3 5 2.5 %
12. 1 + 2 + 4 1 0.5 %
13. 3 + 4 1 0.5 %
Total 204 100.0 %
Dopamine is the commonly used inotrope as a single vasoactive agent (82/204; 
40.2%).  When  more  than  one  inotrope  is  used,  combination  of  dopamine  with 
noradrenaline is predominantly used(45/204; 22.1%).
Table – 9: ROUTE OF ADMINISTRATION 
S. no. Route No. of cases Percentage
1. Peripheral vein 200 98%
2. Central vein 1 0.5%
3. Intraosseous 3 1.5%
Total 204 100%
Of  the  204  cases  studied  200  cases  were  treated  with  inotropes  through  the 
peripheral vein. Of the remaining 4 cases one child was treated with cental vein. Of the 
three cases treated through intraosseous route, 2 cases were started with peripheral vein 
later on.
Table – 10 :ADVERSE OUTCOME
S.no. Adverse effect No. of cases Percentage
1. Extravasations 3 1.5%
2. Arrythmias 1 0.5%
3. Hypertension 2 1%
4. Hyperglycemia 6 2.9%
5. No adverse effect 192 94.1%
Total 204 100%
 
Of the 204 cases studied, only in 3 cases extravasations had been encountered 
with the incidence of only 1.5%. The extavasations occurred in two individuals treated 
with adrenaline infusion and one treated with dopamine infusion. Hyperglycemia is the 
commenest adverse effect following the usage of inotropes and its mainly due to the 
adrenaline  infusion.  Three  out  six  children  with  hyperglycemia  received  adrenaline 
infusion.
Table -11 : IMPROVEMENT OF RESPIRATORY RATE, HEART RATE, PULSE 
VOLUME,CAPILLARY REFILLING TIME , LIVER SPAN , BP & URINE 
OUTPUT AFTER TREATING WITH VASOACTIVE AGENTS
S.no.
Duration 
after 
starting 
vasoactive 
agents
RR HR Pulse volume CRT
Liver 
span
Blood 
pressure
Urine 
output
1. Not 
improved
79 28 24 36 33 5 26
2. <6 hours 6 29 65 79 46 52 89
3. 6-12 hours 19 53 20 28 7 38 42
4. 12-24 
hours
18 38 10 15 2 22 10
5. 24-48 
hours
31 28 7 8 0 3 34
6. >48 hours 45 10 1 5 0 3 3
Total 198 186 127 171 88 123 204
In  the  above  table  numerical  denotes  the  number  of  children.  The  total  total 
number denotes that particular parameter was abnormal, which improved over that given 
time  interval.  Other  missing  number  of  cases  were  having  normal  findings  before 
starting the vasoactive agent.
      Respiratory rate improved in most cases (45/198; 22.7%) only after 48 hours. Heart 
rate  in  the  time  interval  of  6-12  hours  in  most  cases(53/186;  28.5%).  All  other 
parameters  improved within 6 hours.  The percentage  of  children improved within 6 
hours are:  pulse volume-51.2%, capillary refilling time-46.2%, liver span-52%,  Blood 
pressure-42.3%, urine output-43.6%.
Table – 12: INTUBATION
S.no. Intubation No. of cases Percentage
1. Needed 192 94.1%
2. Not needed 12 5.9%
Total 204 100%
Of the 204 cases studied, 12 cases (5.9%) were not intubated and all other cases 
were intubated (94.1%).
Table – 13 : TYPES OF VENTILATION
S.no. Types of ventilation No. of cases Percentage
1. Mechanical alone 0 0
2. Manual alone 113 58.9%
3. both 79 41.1%
Total 192 100%
From the above table, it shows that of the 192 intubated child, 113 children were 
ventilated with manual method alone. Only 41%, that is 79 children had mechanical 
ventilation after few hours to days of manual ventilation.
Table – 14: LAB ABNORMALITIES
S.no. Lab abnormalities No. of cases Percentage
1. No abnormalities 148 72.5%
2. Dyselectolytemia 10 4.9%
3. Hypoglycemia 2 1%
4. Hyperglycemia 8 3.9%
5. Coagulopathy 1 0.5%
6. Anemia 5 2.5%
7. Thrombocytopenia 21 10.3%
8. Renal failure 9 4.4%
Total 204 100%
From the above data, it is clear that thrombocytopenia (21 cases) is the major 
abnormality  noted  in  the  study  group.  Next  order  of  abnormalities  is  the 
Dyselectolytemia(10 cases)  and the renal failure( 9 cases).
Table – 15 : DURATION OF VENTILATION
Hrs No. of cases Percentage Valid 
percentage
0-6 20 9.8 10.4
7-24 65 31.9 33.9
25-72 64 31.4 33.3
>72 43 21.1 22.4
Total 192 94.1 100
Of  the  192  ventilated  children,  most  were  ventilated  for  7-24  hours.
(65/192;31.9%)
Table – 16 : DURATION OF STAY
S.no Duration(hrs) No of cases Percentage Valid %
1 0-6 42 20.6 21.5
2 6-24 69 33.8 35.4
3 25-72 84 41.2 43.1
4 >72 195 95.6 100
 From the above table, it is clear that more than 95% of  the children had stayed 
for more than 3 days in the PICU
Table – 17: OUTCOME
S.no Outcome No of cases Percentage
1 Discharged 98 48
2 Expired 100 49
3 AMA 6 2.9
4 Total 204 100
From the above table, it is evident that mortality rate of the shock patients treated 
with inotropes is 49%.
Table – 18 : VASOACTIVE AGENT USED AND OUTCOME
S.NO Inotropes
Discharged(no 
of cases/%)
Expired(no 
of cases/
%)
AMA Total
1 Dopamine 51(25%) 28(13.7%) 3(1.5%) 82
2 Dobutamine 6(2.9%) 8(3.9%) 0 14
3 Nor 
epinephrine
0 0 0 0
4 Adrenaline 1(0. 5%) 9(4.4%) 0 10
5 1+3 33(16.2%) 11(5.4%) 1(0.5%) 45
6 1+4 1(0.5%) 20(9.8%) 2(1%) 23
7 2+4 0 5(2.5%) 0 5
8 1+3+4 1(0.5%) 8(3.9%) 0 9
9 1+2 3(.5%) 4(2%) 0 7
10 2+3 1(0.5%) 1(0.5%) 0 2
11 1+2+3 0 5(2.5%) 0 5
12 1+2+4 0 1(0.5%) 0 1
13 3+4 1(0.5%) 0 0 1
From the above table, it is clear that when dopamine is used as a single agent (in 
82  cases),the  mortality  rate  is  13.7%(28  cases).  In  more  than  one  inotrope  usage, 
dopamine  and  nor-epinephrine  has  favourable  outcome  of   33  children  discharged 
among the 45 children used.
With the above table we are able to derive a chi square value of 63.433 and p 
value of 0.0001, which is significant.
Table – 19: EXTRAVASATION AND THE OUTCOME
S.NO Extravasatio
n
Discharged Expired AMA Total
1 Occurred 1(0.5%) 1(0.5%) 1(0.5%) 3
2 Not occurred 97(47.5%) 99(48.5%) 5(2.5%) 201
With the above table we are able to derive a chi square value of 9.852 and p value 
of 0.007, which is significant.
Table – 20 : ARRHYTHMIAS AND THE OUTCOME
S.NO Arrhythmia Discharge Death AMA Total
1 Developed 1(0.5%) 0 0 1
2 Not developed 97(47.55%) 100(49%) 6(2.9%) 203
With the above table we are able to derive a chi square value of 1.087 and p value 
of 0.581, which is not  significant.
Table – 21 : HYPERTENSION AND THE OUTCOME
SNO Hypertension Discharged Death AMA Total
1 Developed 0 2(1%) 0 2
2 Not developed 98(48%) 98(48%) 6(2.9%) 202
From the above collected data,chi square value derived is 2.101 and the p value is 
0.350, which is not  significant.
Table – 22 : HYPERGLYCAEMIA ND THE OUTCOME
SNO Hyperglycaemia Discharged Death AMA Total
1 Developed 1(0.5%) 4(2%) 1(0.5%) 6
2 Not developed 97(47.5%) 96(47.1%) 5(2.5%) 198
From the above collected data, chi square value derived is 5.619 and the p value is 
0.06.
Table – 23 :INTUBATION AND OUTCOME
Sno Intubation Discharged Death AMA Total
1 Needed 86(42.2%) 100(49%) 6(2.9%) 192
2 Not needed 12(5.9%) 0 0 12
From the above table we derive a chi square value of 13.79 and a p value of 
0.001,which is significant.
DISCUSSION
 In  the present  study the maximum patients  with shock were observed in  the 
infancy. This is also reported by Daljit singh et al in their study.
In  our  study,  we  found  that  septic  shock  is  the  most  common  type  of 
shock(66.2%) followed by cardiogenic  shock(21.1%),  hypovolemic  shock(8.3%) and 
distributive shock(3.9%).This is  in contrary to the previous studies which showed that 
hypovolemic shock is common type of shock among children.
The total amount of fluid given before the start of inotropes as boluses is less than 
20 ml/kg in more than half of the shock patient in our study population. And 64.7% of 
the patient required less than 100 ml/kg as the total fluid received in 24 hours along with 
the inotropic study. Joseph A Carcillo et al(19) in their study concluded that in shock 
large fluid deficits typically exist, and initial volume resuscitation usually requires 40 to 
60 ml/kg but can be as much as 200ml/kg.In our study, less than 20ml/kg was given 
even though more number of cases had septic shock.
The adverse outcome due to the usage of inotropes through the peripheral venous 
infusion is less with extravasation being 1.5%, arrhythmias 0.5%, hypertension 1% and 
hyperglycaemia 2.9%. The incidence of arrhythmias after administration of inotropes 
was high (23.3%) in the study conducted by Patel et al.
There is no clear cut study for the usage of inotropes in peripheral vein and it  
outcome like extravasation, as most of the centres are using central vein as the route of 
administration. In a hospital like our institution, it is practically difficult to secure central 
vein for all the shock patients treated in PICU as the input of cases is very high. 98% of 
the individuals are treated with vasoactive agents through peripheral vein, 0.5% with 
cntral vein and 1.5% through intraosseous route.
Of  the  shock  patients  analysed  in  our  study,  most  patients  presented  with 
compensated shock (88.7%) and decompensated shock were 11.3%. In the study done 
by Daljit singh et al, where they observed out of 98 patients 39 patients were presented 
with decompensated shock (39.8%).
Of  the  204  patients  included  in  our  study,for  whom inotropes  were  used,106 
patients  were  treated  with  single  vasoactive  agent  and  mortality  rate  among  those 
children  is  42%.In  remaining  98  patients  more  than  one  inotrope  were  used  and 
mortality rate among those patients were 56%. This can be compared with the study 
done by Daljit singh et al, in which mortality rate is 47.9% for those patients with single 
inotrope usage when compared with usage of more than one inotrope with mortality rate 
of 84.1%. In the present study the mortality rate is better when compared to Daljit singh 
et al study.
In the study conducted by Kutko et  al,the mortality rate was more in patients 
requiring  multiple inotropes(42.9%) than patients requiring single inotrope(0%).It  is 
much higher in our study when compared this study.
SUMMARY AND CONCLUSION
 The etiology of shock varies with age groups with incidence decreasing as age 
advances
 Most of the shock is presented as compensated shock with septic shock being the 
most common type of shock in children admitted in PICU.
 Dopamine is the single most common inotropic agent used in the management of 
shock.
 In our study almost all patient tearted for shock, peripheral venous infusion is the 
route of administration for inotropic agent.
 Even though  the children were treated with inotropes through peripheral venous 
infusion, the adverse reaction particularly extravasation is very minimal and so it 
can be safely used in resource poor settings in which central vein cannot be used 
for infusion of inotropic agents.
 Shock patient treated with more than one than inotropic support have a higher 
mortality rate than those patient treated single inotrope support, mortality rate is 
doubled  in  those  patient  presented  with  decompensated  shock  while  starting 
vasoactive agent.
RECOMMENDATION
Inotropes can be safely used through the peripheral venous infusion in resource 
poor settings like our country. 
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Vasoactive agents used and its outcome
1-discharged; 2-death; 3-AMA
Extravasations and the outcome
1-extravasation occurred; 2-extravasations not occurred
Intubation and the outcome
1-intubation needed; 2-intubation not needed
PROFORMA
FOR CRITICALLY ILL CHILDREN TREATED WITH
VASOACTIVE AGENTS IN PICU
NAME:                              AGE:            SEX:          IP No.:
WEIGHT:
TYPE OF SHOCK:   Hypovolemic / Cardiogenic / Distributive / Obstructive/septic
DEGREE OF SHOCK:  Compensated / Decompensated
HEMODYNAMIC STATUS WHILE STARTING VASOACTIVE AGENT(S):
Respiratory rate:-     /min
Heart rate:-       /min
Pulse volume:-
CRT:- Normal / prolonged / flash refill
Liver span:-      cm
Blood pressure:-            mm of HG
AMOUNT OF FLUID GIVEN BEFORE STARTING VASOACTIVE AGENT(S):- 
ml/kg
1 hour 6 hours 12 hours 24 hours
Total fluid 
received
Urine 
output
VASOACTIVE AGENTS USED:- Dopamine/ Dobutamine/Noradrenaline/  Adrenaline / 
Others      
TIME OF STARTING VASOACTIVE AGENT FROM ARRIVAL:-
ROUTE OF ADMINISTRATION: Central vein/peripheral vein/intraosseous
NUMBER OF IV LINES USED:-
NUMBER OF INFUSION PUMPS USED:-
Inotropes
Initial 
dose
Maximum 
dose
Time taken 
to reach the 
maximum 
dose
Maximum 
dose 
maintained 
for
Weaning 
period
Restarted
Dopamine
Dobutamine
Noradrenalin
e
Adrenaline
Others
COMPLICATIONS:-        
Extravasations/Arrhythmias/Hypertension/Hyperglycemia/Others
MONITORING:-
Time RR
H
R
Pulse 
volume
CRT
Blood 
pressure
Urine 
output
Saturation
INTUBATION:-Needed/Not needed{Manual/Mechanical}
                           Duration of ventilation ____hours
LAB ABNORMALITIES IF ANY {Related to-
Dyselectrolytemia/Hypoglycemia/Hyperglycemia/Coagulopathy/Anemia/
Thrombocytopenia/Renal failure}:-
DURATION OF STAY IN THE PICU:-
OUTCOME:-

